FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

11760911000001101: Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42805201000001119 Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62009001000001118 Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oromucosal gel 15 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Is pack of Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has active ingredient Cetylpyridinium chloride false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has VMP Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has specific active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has specific active ingredient Cetylpyridinium chloride true Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Has dispensed dose form Conventional release oromucosal gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sore Mouth gel (The Boots Company Plc) 15 gram Is a True Lidocaine 0.6% / Cetylpyridinium chloride 0.02% oral gel 15 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start